Perspectives on Cost and Outcomes for Point-of-Care Testing
Perspectives on Cost and Outcomes for Point-of-Care Testing
复制标题
DOI：
10.1016/j.cll.2009.07.001
复制
发表时间：
2009-09-01
影响因子：
1.7
通讯作者：
Lewandrowski, Kent
中科院分区：
文献类型：
--
作者：
Lee-Lewandrowski, Elizabeth;Lewandrowski, Kent
按单位成本计算，即时检测（POCT）通常比在中心实验室进行的检测更昂贵。管理POCT和保持法规遵从性是困难的，特别是在大型机构中。然而，一些POCT技术已经改善了患者的预后（患者在家中进行自我血糖监测，在重症监护环境中进行严格的血糖控制）或医院或急诊科的操作（在急诊科进行全血心脏标志物检测和d -二聚体检测）。在某些情况下，这些结果仅仅是因为提供了一种新的测试，而不是在护理点进行测试。在大多数情况下，POCT提供的快速周转时间是最终改善结果的主要因素。
Point-of-care testing (POCT) is usually more expensive on a unit-cost basis than testing performed in a central laboratory. It is difficult to manage POCT and to maintain regulatory compliance, especially in large institutions. However, some POCT technologies have improved patient outcomes (patient self-glucose monitoring in the home, tight glycemic control in intensive care settings) or hospital or emergency department operations (whole-blood cardiac-marker testing and D-dimer testing in emergency departments). In some cases, these outcomes result simply from making a new test available, rather than performing the test at the point of care. In most cases, the rapid turnaround time provided by POCT is the main factor that is ultimately responsible for the improvement in outcomes.